Evidence map›Paper›PMID 18025095›Full record

ArticleInfection and immunity2008

Identification of immunologic and pathologic parameters of death versus survival in respiratory tularemia.

Damiana Chiavolini, Joseph Alroy, Carol A King, Peter Jorth, Susan Weir, Guillermo Madico, John R Murphy, Lee M Wetzler

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. The immune response toFrontiers in microbiology · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Infection and immunity · 2018
    Article
  7. Article
  8. DifferentialFrontiers in immunology · 2018
    Article
  9. Article
  10. Isolation ofFrontiers in microbiology · 2017
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Damiana ChiavoliniDepartment of Medicine, Boston University School of Medicine, Boston, Massachusetts 02118, USA.
Joseph Alroy
Carol A King
Peter Jorth
Susan Weir
Guillermo Madico
John R Murphy
Lee M Wetzler
Tufts Medical Center · US

Funding

Immuno-Prophylaxis-Therapy &Diagnosis of TularemiaU19AI056543 · NIAID · BOSTON MEDICAL CENTER · PI MURPHY, JOHN R. · 2003 to 2007
$10.5M
NIAID NIH HHS U19 AI056543
6 · The paper itself

Abstract

Francisella tularensis can cause severe disseminated disease after respiratory infection. The identification of factors involved in mortality or recovery following induction of tularemia in the mouse will improve our understanding of the natural history of this disease and facilitate future evaluation of vaccine candidate preparations. BALB/c mice were infected intranasally with the live vaccine strain (LVS) of F. tularensis subsp. holarctica and euthanized at different stages of disease to analyze the induction of immune molecules, gross anatomical features of organs, bacterial burdens, and progression of the histopathological changes in lung and spleen. Tissue-specific interleukin-6 (IL-6), macrophage inflammatory protein 2, and monocyte chemotactic protein 1 were immune markers of mortality, while anti-LVS immunoglobulin M and IL-1beta were associated with survival. Moribund mice had enlarged spleens and lungs, while surviving mice had even more prominent splenomegaly and normal-appearing lungs. Histopathology of the spleens of severely ill mice was characterized by disrupted lymphoid follicles and fragmented nuclei, while the spleens of survivors appeared healthy but with increased numbers of megakaryocytes and erythrocytes. Histopathology of the lungs of severely ill mice indicated severe pneumonia. Lungs of survivors at early time points showed increased inflammation, while at late times they appeared healthy with peribronchial lymphoid aggregates. Our results suggest that host immune factors are able to affect bacterial dissemination after respiratory tularemia, provide new insights regarding the pathological characteristics of pulmonary tularemia leading to systemic disease, and potentially identify immune markers associated with recovery from the disease.

Indexed as

AnimalsAntibodies, BacterialBody WeightChemokine CCL2Chemokine CXCL2Colony Count, MicrobialFemaleFrancisella tularensisImmunoglobulin MInterleukin-1betaInterleukin-6LungMiceMice, Inbred BALB COrgan SizePneumoniaAntibodies, BacterialChemokine CCL2Chemokine CXCL2Immunoglobulin MInterleukin-1betaInterleukin-6

Identifiers

PMID18025095
PMCPMC2223482
OpenAlexW2167950398

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.